Enzalutamide 160mg Tablet

Enzalutamide 160mg Tablet contains enzalutamide, a prescription androgen receptor inhibitor used in the treatment of certain types of advanced prostate cancer. It works by blocking androgen receptor signaling, which can help slow the growth and progression of prostate cancer cells.

Xtandi® is the reference brand containing enzalutamide. Enzalutamide products may be available under different brand names depending on the manufacturer and country.

Product Information

• Generic Name: Enzalutamide 160mg
• Drug Class: Androgen Receptor Inhibitor / Antiandrogen
• Reference Brand: Xtandi®
• Indication: Advanced Prostate Cancer
• Form: Tablet
• Strength: 160mg
• Route: Oral
• Prescription: Yes
• Active Ingredient: Enzalutamide
• Packing: Manufacturer Dependent

How It Works

Enzalutamide blocks the androgen receptor signaling pathway. It interferes with androgen binding to the receptor and inhibits downstream receptor activity that can promote the growth and survival of prostate cancer cells.

By suppressing androgen receptor signaling, enzalutamide can help slow the progression of androgen-dependent prostate cancer.

Uses

Enzalutamide 160mg may be prescribed for eligible patients with certain forms of advanced prostate cancer, including:

• Metastatic castration-resistant prostate cancer (mCRPC)
• Non-metastatic castration-resistant prostate cancer (nmCRPC)
• Metastatic hormone-sensitive prostate cancer (mHSPC) in appropriate treatment settings

The approved indications and treatment combinations vary according to country, regulatory approval, and individual patient circumstances.

Enzalutamide 160mg and Xtandi®

Xtandi® is the reference brand for enzalutamide. Enzalutamide 160mg Tablets contain the same active pharmaceutical ingredient, enzalutamide.

For SEO, the strongest primary product name is:

Enzalutamide 160mg Tablet

Supporting terms can include Generic Xtandi®, Xtandi alternative, Enzalutamide 160mg, Enzalutamide prostate cancer medicine, and Enzalutamide androgen receptor inhibitor where appropriate.

Availability & Ordering

Patients searching for Enzalutamide 160mg Tablet, Buy Enzalutamide Online, Enzalutamide 160mg Price, Generic Xtandi®, Xtandi Alternative, Enzalutamide Prostate Cancer Medicine, Enzalutamide Hormone Therapy, and Androgen Receptor Inhibitor can find prescription oncology medicines through licensed pharmaceutical suppliers, subject to local prescription and pharmaceutical regulations.

Frequently Asked Questions

What is Enzalutamide 160mg Tablet used for?

Enzalutamide is used to treat certain types of advanced prostate cancer, including specific forms of metastatic and non-metastatic castration-resistant and metastatic hormone-sensitive prostate cancer.

What is the active ingredient in Enzalutamide 160mg?

The active ingredient is enzalutamide 160mg.

Is Enzalutamide 160mg the generic of Xtandi®?

Xtandi® is the reference brand containing enzalutamide. Enzalutamide products may be marketed as generic or equivalent products depending on the specific product’s regulatory authorization.

How does Enzalutamide work?

Enzalutamide blocks androgen receptor activity, reducing androgen-driven signaling that can contribute to prostate cancer cell growth.

How is Enzalutamide 160mg taken?

The usual adult dose is 160mg once daily, taken orally, but treatment should always follow the prescribing instructions provided by the treating oncologist.

Is Enzalutamide a chemotherapy medicine?

Enzalutamide is generally classified as a hormonal/androgen receptor-targeted cancer medicine, rather than traditional cytotoxic chemotherapy.

Does Enzalutamide require medical supervision?

Yes. Enzalutamide is a prescription anticancer medicine and should be used under the supervision of an oncologist or qualified healthcare professional.

Last Updated: August 21, 2026 | Medically Reviewed By: Licensed Pharmacist

Medical Disclaimer: This information is provided for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Enzalutamide should be used only under the supervision of a qualified oncology professional.